Pfizer: Activists Clouding A Promising Picture

Summary:

  • Pfizer’s deep valuation and large dividend yield make it an attractive investment, despite potential distractions from activist investors.
  • The focus should remain on existing cost realignment plans and pipeline investments to ensure positive financial returns for shareholders.
  • The stock only trades at 10x forward EPS targets.
Pfizer Canada head office in Kirkland, Quebec, Canada.

JHVEPhoto

As 2024 comes to an end, Pfizer Inc. (NYSE:PFE) (NEOE:PFE:CA) was poised to return to growth. Oddly, activists are now swarming the biopharma for changes the company already appears to be implementing, clouding the story. My


Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in PFE over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

The information contained herein is for informational purposes only. Nothing in this article should be taken as a solicitation to purchase or sell securities. Before buying or selling any stock, you should do your own research and reach your own conclusion or consult a financial advisor. Investing includes risks, including loss of principal.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.


If you’d like to learn more about how to best position yourself in under valued stocks mispriced by the market to start Q4, consider joining Out Fox The Street

The service offers a model portfolio, daily updates, trade alerts and real-time chat. Sign up now for a risk-free 2-week trial. 

Leave a Reply

Your email address will not be published. Required fields are marked *